GXMC
KERX

Global X Management Company’s Keryx Biopharmaceuticals Inc KERX Stock Holding History

Global X Management Company’s Portfolio KERX Stock Details KERX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-1,357
Closed -$19K – 586
2014
Q3 		$19K Buy
+1,357
New +$20.8K ﹤0.01% 483

Other funds holding KERX

BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return
ORI
Oak Ridge Investments Chicago, Illinois $1.77B AUM 63.16% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Global X Management Company's KERX Position: Q4 2014 in Review

Global X Management Company sold out of Keryx Biopharmaceuticals Inc (KERX) in Q4 2014, closing a stake of 1,357 shares — an estimated $19K sold.

Global X Management Company first reported a position in KERX in Q3 2014 and held it in 1 quarter. The position peaked at $19K in Q3 2014. 147 funds tracked by Wall St. Rank hold KERX as of Q4 2014.

  • Global X Management Company reported no remaining Keryx Biopharmaceuticals Inc position as of Q4 2014 after selling out during the quarter.
  • Global X Management Company sold 1,357 Keryx Biopharmaceuticals Inc shares in Q4 2014, an estimated $19K.
  • Global X Management Company first reported a position in Keryx Biopharmaceuticals Inc in Q3 2014 and held it in 1 quarter.
  • Global X Management Company's Keryx Biopharmaceuticals Inc position peaked at $19K in Q3 2014.
  • 147 funds tracked by Wall St. Rank held Keryx Biopharmaceuticals Inc as of Q4 2014.

Based on Global X Management Company's 13F filing for Q4 2014, filed 12 Feb 2015.